Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 103616
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103616
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103616
Figure 6 Mechanism of glucose disorder amelioration by bile powder-mediated intestinal glucagon-like peptide-1 secretion.
Our study revealed that bile powder interacts with the intestinal enteroendocrine L cells to inhibit farnesoid X receptor signaling and to promote glucagon-like peptide-1 production. Bile powder is a glucagon-like peptide-1 stimulator and attenuates blood glucose impairment. GLP-1: Glucagon-like peptide-1; FXR: Farnesoid X receptor.
- Citation: Sun YM, Kuang JL, Zhang HH, Xia XX, Wang JY, Zheng D, Zhou KJ, Tang YJ, Zhao AH, Jia W, Xie GX, Zheng XJ. Pig bile powder maintains blood glucose homeostasis by promoting glucagon-like peptide-1 secretion via inhibiting farnesoid X receptor. World J Diabetes 2025; 16(6): 103616
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/103616.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.103616